Post-approval studies (Phase 4)WithdrawnNCT03898973What this trial is testingResponse to Inactivated Influenza Vaccine in Lymph Tissue and BloodWho this might be right forInfluenza Stanford University
Large-scale testing (Phase 3)Study completedNCT01880697What this trial is testingSafety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and AboveWho this might be right forHuman Influenza Novartis Vaccines 126
Large-scale testing (Phase 3)Study completedNCT06602024What this trial is testingMRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of AgeWho this might be right forSeasonal Influenza ModernaTX, Inc. 40,805
Early research (Phase 1)Study completedNCT00231920What this trial is testingInactivated Influenza Vaccine in Infants 10-22 Weeks of AgeWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 23
Large-scale testing (Phase 3)Study completedNCT00192413What this trial is testingTrial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed InfluenzaWho this might be right forInfluenza MedImmune LLC 3,009
Testing effectiveness (Phase 2)Study completedNCT01089660What this trial is testingThe Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy AdultsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 202
Large-scale testing (Phase 3)Study completedNCT02285998What this trial is testingProtective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of AgeWho this might be right forInfluenza Protein Sciences Corporation 9,003
Testing effectiveness (Phase 2)Study completedNCT01494740What this trial is testingImmunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in InfantsWho this might be right forInfluenza Shanghai Institute Of Biological Products 312
Early research (Phase 1)Study completedNCT00532792What this trial is testingA/H5N1 Dose Ranging Study With Adjuvant PatchWho this might be right forPandemic Influenza Intercell USA, Inc. 501
Not applicableStudy completedNCT03694392What this trial is testingFlublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 YearsWho this might be right forInfluenzaPneumoniaLower Respiratory Tract Infection+3 more Kaiser Permanente 2,776,278
Large-scale testing (Phase 3)Study completedNCT01551823What this trial is testingThe Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)Who this might be right forInfluenza Institute of Medical Biology, Chinese Academy of Medical Sciences 1,200
Post-approval studies (Phase 4)Study completedNCT01654224What this trial is testingRandomized Trial of High Dose Influenza Vaccine in Long Term Care SettingWho this might be right forInfluenza University of Pittsburgh 205
Early research (Phase 1)Study completedNCT00995982What this trial is testingVRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 YearsWho this might be right forInfluenza, Human National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableUnknownNCT05315024What this trial is testingInfluenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive ChildrenWho this might be right forInfluenza The University of Hong Kong 72
Not applicableWithdrawnNCT00417560What this trial is testingInactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 VirusesWho this might be right forInfluenza Centers for Disease Control and Prevention
Testing effectiveness (Phase 2)Study completedNCT00545701What this trial is testingImmunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in AdultsWho this might be right forInfluenzaOrthomyxoviridae Infections Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT00718146What this trial is testingImmunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 FormulationWho this might be right forInfluenzaOrthomyxoviridae Infections Sanofi Pasteur, a Sanofi Company 130
Testing effectiveness (Phase 2)Study completedNCT01152814What this trial is testingStudy to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011Who this might be right forSeasonal Influenza Novartis Vaccines 64
Not applicableStudy completedNCT01180699What this trial is testingIntradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant RecipientsWho this might be right forInfluenza Vaccine University of Alberta 229
Not applicableStudy completedNCT06059456What this trial is testingSafety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24Who this might be right forInfluenza Immunization (Healthy Volunteers) Sanofi 2,078